Embecta Corp. (EMBC) Stock | EMBC Stock Price & Analysis

Feed

EMBC

Embecta Corp. EMBC · NASDAQ

$6.21 -0.96% (-$0.06)

Summary

66 / 100 · Bulios Score

Valuation 100Growth 5Profitability 89Quality 80Debt 33Stability 82

What speaks for it

It earns 18 USD a year on every 100 USD of invested capital.
The share price is below the Bulios Fair Price.
Out of every 100 USD of revenue, 16 USD is left as free cash.

What to watch

Earnings per share fell by 25% a year over the last 3 years.
Repaying its net debt would take 4.7 years of operating profit.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Looks cheap

Bulios Fair Price

Current price $6.21

5-year average P/E 9.7 59% lower

P/E today 4.0

Medical - Instruments & Supplies industry median

P/E today 4.0

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 4.0 USD for 1 USD of yearly profit. Over the last five years it was 9.7 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

1.2B

1.1B

1.0B

1.1B

2021202220232024202520262027

Diluted EPS (USD)

$7.31

$3.89

$1.22

$1.34

$1.62

$1.84

$1.76

2021202220232024202520262027

Analyst estimate

Revenue fell by 0.1% a year over 5 years. Over the last 3 years it fell by 1.5% a year. Earnings per share fell by 25% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Cost of sales 40 USD
Research and development 2.0 USD
Sales and administration 33 USD
Taxes and other 16 USD
Net profit 8.6 USD

Net profit, industry median (Medical - Instruments & Supplies) 8.1 USD

Out of every 100 USD of revenue, 8.6 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Cash and short-term investments $214.7M

Debt $1.50B

Free cash flow over 12 months $164.6M

Repaying all its debt would take 9.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, safe

0.00

0.30

0.60

20212022202320242025

Yield: 5.15%
Paid out of profit: 21%

You receive $0.32 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Neutral

Buy 0
Hold 2
Sell 2

Today's price within the analysts' price targets

Today's price $6.21 Average target $5

$5 $6.21

The average target of $5 is 19% below today's price. 0.0% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

Safety 80%
Manufacturing Facility 12%
Product and Service, Other 8.2%

By region

UNITED STATES 54%
Non-US 46%

Safety brings in 80% of revenue.

Segments in detail